Articles By Rob Wright, Chief Editor 2011-2021
-
![CEO Outlook_bucket_450x300]( "Prophecy & Prognostication 2.0 — A Charting Of Biopharma's Future")
Prophecy & Prognostication 2.0 — A Charting Of Biopharma's Future12/3/2018We asked multiple biopharma CEOs everything from which executives or companies they pay close attention to in and outside of their industry, to questions about geopolitical issues, tech trends, and everything in between.
-
![Rob Wright_2017_450x300]( "What Does The Future Hold?")
What Does The Future Hold?12/3/2018Chief editor, Rob Wright, discusses some forward-looking sessions from the annual CNS Summit, along with what to expect in Life Science Leader’s annual outlook issue.
-
![Manufacturing_bucket_450x300]( "The Future Of Biopharma Hinges On The Ability To Manufacture")
The Future Of Biopharma Hinges On The Ability To Manufacture12/3/2018Industry experts answer questions around future biopharma manufacturing trends, challenges, technologies, performance metrics, risk mitigation, people, and outsourcing.
-
![Finance_bucket_450x300]( "Forecasting Biopharma's Financial Future")
Forecasting Biopharma's Financial Future12/3/2018We connected with a collection of biopharma financial experts to get you prepared for JPM, BTS, and the BIO CEO & Investors Conference in the first quarter of 2019.
-
![CNS Summit 2018 Does Not Meet Expectations — It Exceeded Them]( "CNS Summit 2018 Does Not Meet Expectations — It Exceeded Them")
CNS Summit 2018 Does Not Meet Expectations — It Exceeded Them11/16/2018Rob Wright shares what makes the CNS Summit the best conference he has ever attended.
-
![Liz Barrett_450x300_1]( "Liz Barrett — Novartis Oncology's NextGen Leader")
Liz Barrett — Novartis Oncology's NextGen Leader11/7/2018Liz Barrett shares some of the formative experiences that shaped her into the leader she has become, including one of the most recent challenges she is embracing at Novartis.
-
![Rob Wright_2017_450x300]( "When One Door Closes…")
When One Door Closes…11/7/2018A tour of the Netherlands’ life sciences industry takes our chief editor back to the global headquarters of his former employer, Organon Pharmaceuticals.
-
![Netherlands IMG_7911]( "The Netherlands — More Than Just The New Home Of The EMA")
The Netherlands — More Than Just The New Home Of The EMA11/1/2018What sets the Netherlands biopharma sector apart from the rest of the world? That’s what Chief Editor Rob Wright hoped to find out as he began his press tour of the country’s biopharma industry.
-
![Louis-Schmukler_450x300_2]( "From Big To Specialty — The Operational Transformation Of Bristol-Myers Squibb")
From Big To Specialty — The Operational Transformation Of Bristol-Myers Squibb10/4/2018When Lou Schmukler joined Bristol-Myers Squibb (BMS) in 2011, it was analogous to jumping onto a moving train. The company’s biopharma transformation was barreling ahead at full steam. More change was coming, and the company’s manufacturing operations would need to move fast to keep up.
Rob Wright
Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL